Equity impact analysis of medical approaches to cardiovascular diseases prevention in Tanzania
Bibliographic Data
| ID | 4784791 |
|---|---|
| Authors | Frida N Ngalesoni, Frida Ngalesoni (University of Bergen, corresponding author), George M Ruhago (0000-0001-7469-7822, University of Bergen), Amani T Mori (0000-0002-9968-3635, University of Bergen), Bjarne Robberstad (0000-0002-0708-2016, University of Bergen), Ole F Norheim (0000-0002-5748-5956, University of Bergen) |
| Year | 2016 |
| Volume | 170 |
| Pages | 208-217 |
| Publication date | 2016-12-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Social Science & Medicine (JOURNAL) |
| Journal identifiers | ISSN: 0277-9536 • E-ISSN: 1873-5347 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.socscimed.2016.08.033 |
| PMID | 27590271 |
| OpenAlex | W2509297873 |
| Language | EN |
| Citations received | 3 |
| References cited | 36 |
Primary medical prevention of cardiovascular disease (CVD) has received low priority in Tanzania, despite evidence of the rising prevalence of CVD risk factors. Different guidelines have been proposed for medical CVD prevention, including the European Society of Cardiology (ESC) and the World Health Organization (WHO) guidelines, which recommend medical prevention for all individuals based on the consideration of single CVD risk thresholds. A third alternative is differentiated risk thresholds according to age. This paper compares the WHO and the differentiated risk threshold by age approaches against a baseline of no medical CVD prevention and a best scenario identical to the ESC approach in Tanzania. Assuming fixed budgets, we evaluate the guidelines according to three outcome measures, namely: efficiency, inequality and the combination of efficiency and inequality. We ran a Markov analysis for an estimated Tanzanian population at risk of CVD employing a 40 years time horizon to estimate the total expected costs and CVD deaths associated with provision of the different guidelines. The results were then used to calculate three outcomes: life expectancy at age 40 as a proxy for efficiency, the Gini coefficient (a measure of inequality), and the achievement index (which combines concerns of efficiency and inequality). Our results suggest that higher life expectancy (28.3 vs. 26.6 years) and more equally distributed health (Gini coefficient of 0.22 vs. 0.24) could be attained if medical CVD prevention was based on the differentiated risk threshold approach compared to the WHO single risk threshold, when the total cost of these approaches is the same. Preventing CVD based on differentiating risk thresholds by age seems to be the better alternative when concerns of both efficiency and inequality are considered important. However, further research on the country-specific distribution of CVD risk levels and budget impact analysis are important to assess the feasibility of its implementation
Actuarial science · Economic inequality · Economics · Environmental health · Gini coefficient · Inequality · Life expectancy · Population · Socioeconomics · Tanzania · Demography · Global Public Health Policies and Epidemiology · Health Systems, Economic Evaluations, Quality of Life · Healthcare Systems and Reforms · Medicine
Does the medical insurance system play a real role in reducing catastrophic economic burden in elderly patients with cardiovascular disease in China? Implication for accurately targeting vulnerable characteristics
Distributional cost-effectiveness analysis in low- and middle-income countries
A history that goes hand in hand
Analyzing Health Equity Using Household Survey Data
Inequality aversion, health inequalities and health achievement
Principles for allocation of scarce medical interventions
Global estimates of the prevalence of diabetes for 2010 and 2030
Unfair inequalities in health and health care
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Global burden of hypertension
Non-communicable diseases in sub-Saharan Africa
Equality and Priority
Improving the cost-effectiveness of cardiovascular disease prevention in Australia
Economic cost of primary prevention of cardiovascular diseases in Tanzania
Incorporating concerns for equal lifetime health in evaluations of public health programs
| Unique citing works | 3 |
|---|---|
| Citations per year | 0,38 |
| Citation span | 2018 - 2021 (4) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 3 |